Cargando…

Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086622/ https://www.ncbi.nlm.nih.gov/pubmed/36795079 http://dx.doi.org/10.1093/jnci/djad023

Ejemplares similares

TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
por: Mukhopadhyay, Utpal K, et al.
Publicado: (2019)

Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Correction: TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions
por: Shirole, Nitin H, et al.
Publicado: (2017)

TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions
por: Shirole, Nitin H, et al.
Publicado: (2016)

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
por: Joshi, H, et al.
Publicado: (2012)

Correction: DOR/Tp53inp2 and Tp53inp1 Constitute a Metazoan Gene Family Encoding Dual Regulators of Autophagy and Transcription
por: Sancho, Ana, et al.
Publicado: (2012)

Correction: DOR/Tp53inp2 and Tp53inp1 Constitute a Metazoan Gene Family Encoding Dual Regulators of Autophagy and Transcription
por: Sancho, Ana, et al.
Publicado: (2012)

Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Correction: Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
por: Bossard, Carine, et al.
Publicado: (2013)

Author Correction: Interaction between the microbiome and TP53 in human lung cancer
por: Greathouse, K. Leigh, et al.
Publicado: (2020)

Oxidative Stress Induced by MnSOD-p53 Interaction: Pro- or Anti-Tumorigenic?
por: Robbins, Delira, et al.
Publicado: (2012)

TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study
por: Hurson, Amber N., et al.
Publicado: (2022)

Correction: PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner
por: Luo, Dehong, et al.
Publicado: (2019)

Correction to: The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma
por: Yuan, Lin, et al.
Publicado: (2021)

Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta
por: Madar, Shalom, et al.
Publicado: (2013)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Publicado: (2021)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2020)

Correction: The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat
por: Kurz, Susanne, et al.
Publicado: (2018)

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2009)

Mutant p53 elicits context-dependent pro-tumorigenic phenotypes
por: McCann, Jennifer J., et al.
Publicado: (2021)

Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer
por: Suresh, Shruthy, et al.
Publicado: (2018)

Author Correction: Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix
por: Kay, Emily J., et al.
Publicado: (2022)

TP 53 status and estrogen receptor-beta in triple negative breast cancer management in Africa: Time to rethink regime management of triple negative breast cancer and save more lives in Nigeria
por: Nzegwu, Martin Arinzechukwu, et al.
Publicado: (2021)

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status
por: Gottlieb, Aline, et al.
Publicado: (2017)

Correction: Xenoestrogens Alter Estrogen Receptor (ER) α Intracellular Levels
Publicado: (2014)

Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study
por: Schetelig, Johannes, et al.
Publicado: (2021)

Correction: The association between TP53 rs1625895 polymorphism and the risk of sarcopenic obesity in Iranian older adults: a case-control study
por: Montazeri-Najafabady, Nima, et al.
Publicado: (2022)

Correction: The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
Publicado: (2014)

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
por: Assumpção, Juliana G, et al.
Publicado: (2011)

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004)

Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2012)

Pro‐tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma
por: Portela, R.F., et al.
Publicado: (2014)

Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
por: Di Leva, Gianpiero, et al.
Publicado: (2013)

Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
por: Sznarkowska, Alicja, et al.
Publicado: (2019)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

Analysis of the TP53 Deleterious Single Nucleotide Polymorphisms Impact on Estrogen Receptor Alpha-p53 Interaction: A Machine Learning Approach
por: Chitrala, Kumaraswamy Naidu, et al.
Publicado: (2019)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k4jm0tn7g4s1c1jcl36qbbqiqi